Potential Klebsiella Bacteriocin with Efficacy Toward the Enterobacteriaceae Family
Faculty Mentor
Dr. Sean Fox
Mentor Home Department
Health Sciences
Short Abstract
Drug resistance is a prevalent issue in patient treatment. The CDC estimates 23,000 people die yearly in the United States from antibiotic-resistant infections. Microbes produce a range of antimicrobials: antibiotics, metabolites, and lytic agents. Bacteriocins differ from antibiotics as they have a narrow killing spectrum and toxicity to bacteria. We characterized a Klebsiella bacteriocin by isolating a plasmid from Klebsiella that encodes a novel bacteriocin with efficacy towards Enterobacteriaceae family members and offers alternative treatment for drug resistant.
Category
Science and Technology
Start Date
24-4-2023 9:00 AM
End Date
24-4-2023 9:15 AM
Location
D.P. Culp Center Room 271J
Potential Klebsiella Bacteriocin with Efficacy Toward the Enterobacteriaceae Family
D.P. Culp Center Room 271J
Drug resistance is a prevalent issue in patient treatment. The CDC estimates 23,000 people die yearly in the United States from antibiotic-resistant infections. Microbes produce a range of antimicrobials: antibiotics, metabolites, and lytic agents. Bacteriocins differ from antibiotics as they have a narrow killing spectrum and toxicity to bacteria. We characterized a Klebsiella bacteriocin by isolating a plasmid from Klebsiella that encodes a novel bacteriocin with efficacy towards Enterobacteriaceae family members and offers alternative treatment for drug resistant.